CL2020003220A1 - Nueva proteína con propiedades antiinflamatorias - Google Patents

Nueva proteína con propiedades antiinflamatorias

Info

Publication number
CL2020003220A1
CL2020003220A1 CL2020003220A CL2020003220A CL2020003220A1 CL 2020003220 A1 CL2020003220 A1 CL 2020003220A1 CL 2020003220 A CL2020003220 A CL 2020003220A CL 2020003220 A CL2020003220 A CL 2020003220A CL 2020003220 A1 CL2020003220 A1 CL 2020003220A1
Authority
CL
Chile
Prior art keywords
inflammatory properties
new protein
seq
prevention
isolated
Prior art date
Application number
CL2020003220A
Other languages
English (en)
Spanish (es)
Inventor
Valerie Mary Corrigall
Gabriel Stavros Panayi
Original Assignee
Immune regulation ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/007,742 external-priority patent/US10858409B2/en
Priority claimed from GBGB1809703.0A external-priority patent/GB201809703D0/en
Application filed by Immune regulation ltd filed Critical Immune regulation ltd
Publication of CL2020003220A1 publication Critical patent/CL2020003220A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CL2020003220A 2018-06-13 2020-12-11 Nueva proteína con propiedades antiinflamatorias CL2020003220A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/007,742 US10858409B2 (en) 2018-06-13 2018-06-13 Protein with anti-inflammatory properties
GBGB1809703.0A GB201809703D0 (en) 2018-06-13 2018-06-13 Novel protein with anti-inflammatory properties

Publications (1)

Publication Number Publication Date
CL2020003220A1 true CL2020003220A1 (es) 2021-10-01

Family

ID=66999851

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020003220A CL2020003220A1 (es) 2018-06-13 2020-12-11 Nueva proteína con propiedades antiinflamatorias

Country Status (14)

Country Link
EP (1) EP3807303A1 (ja)
JP (1) JP2021528100A (ja)
KR (1) KR20210039339A (ja)
CN (1) CN112888704A (ja)
AU (2) AU2019285831B2 (ja)
BR (1) BR112020025398A2 (ja)
CA (1) CA3103370A1 (ja)
CL (1) CL2020003220A1 (ja)
CO (1) CO2020016749A2 (ja)
IL (1) IL279350A (ja)
MX (1) MX2020013569A (ja)
SG (1) SG11202012363XA (ja)
WO (1) WO2019239126A1 (ja)
ZA (1) ZA202100115B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023187422A1 (en) 2022-03-31 2023-10-05 Revolo Biotherapeutics Limited Compositions and their use in methods for treating intestinal inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822115D0 (en) * 1998-10-09 1998-12-02 King S College London Treatment of inflammatory disease
GB0106161D0 (en) 2001-03-13 2001-05-02 King S College London Immunomodulators
DE10127572A1 (de) * 2001-05-30 2002-12-05 Pathoarray Gmbh Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
US20080317761A1 (en) * 2004-04-28 2008-12-25 The Trustees Of The University Of Pennsylvania Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage
EP1874331B1 (en) * 2005-04-19 2014-09-03 Kings College London Use of bip against bone loss and osteoporosis
LT2872644T (lt) * 2012-07-12 2017-10-10 Uab Baltymas Natyvių rekombinantinių sekretuojamų žmogaus endoplazminio tinklo šaperonų gamyba, panaudojant jų natyvias signalines sekas, mielių raiškos sistemose
US20140294902A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide antagonists
KR101731908B1 (ko) * 2015-08-18 2017-05-11 서울대학교산학협력단 p62 ZZ 도메인에 결합하는 리간드 또는 아르기닌화된 BiP에 의해 매개되는 오토파지 활성을 통한 신경변성 질환 예방 및 치료

Also Published As

Publication number Publication date
CN112888704A (zh) 2021-06-01
CO2020016749A2 (es) 2021-04-08
AU2019285831A1 (en) 2021-01-28
MX2020013569A (es) 2021-05-27
ZA202100115B (en) 2022-07-27
AU2024200977A1 (en) 2024-03-07
BR112020025398A2 (pt) 2021-04-06
WO2019239126A1 (en) 2019-12-19
JP2021528100A (ja) 2021-10-21
SG11202012363XA (en) 2021-01-28
AU2019285831B2 (en) 2023-11-16
IL279350A (en) 2021-01-31
KR20210039339A (ko) 2021-04-09
EP3807303A1 (en) 2021-04-21
CA3103370A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
CL2018003322A1 (es) Inhibidores peptídicos del receptor de interleucina 23 y sus uso para tratar enfermedades inflamatorias. (divisional solicitud 201800128)
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
CY1121658T1 (el) Πεπτιδια και χρηση αυτων
NZ730865A (en) Peptides having anti-inflammatory properties
RS53505B1 (en) OXYTOMODULIN PEPTIDE ANALOG
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
EA201990298A1 (ru) Способы и композиции для лечения рака
PE20220505A1 (es) Moleculas de union a tigit y pd-1/tigit
BR112018000660A2 (pt) peptídeos anti-inflamatórios e seu uso
BR112013013548B8 (pt) Proteína de fusão anticancerígena
CO2021017664A2 (es) Péptidos
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
PE20170955A1 (es) Nuevas proteinas inhibidoras de insectos
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
WO2019094938A3 (en) Methods and compositions for the treatment of wounds
AR075933A1 (es) Composiciones polipeptidas y de inmunizacion conteniendo polipeptidos positivos gram y metodos de uso
CO2017013404A2 (es) Variantes de il-37
CL2020003220A1 (es) Nueva proteína con propiedades antiinflamatorias
EA202092963A1 (ru) Новый белок с противовоспалительными свойствами
CU24609B1 (es) Proteína de fusión que comprende una proteína de subunidad de ferritina monomérica unida a una proteína de dominio alfa 3 de mic
ES2526109R2 (es) Péptido y composición farmacéutica para el tratamiento del cáncer
MX2017013480A (es) Composicion farmaceutica para tratar y/o prevenir el cancer.
MX2020004218A (es) Métodos y composiciones para inhibir las actividades biológicas de adam10.